Bibliography

Displaying 76 - 90 of 1866

Antonelli 2010

Antonelli LR, Mahnke Y, Hodge JN, et al. Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. 2010;116:3818-3827.

Apetrei 2004

Apetrei C, Marx PA. Simian retroviral infections in human beings. Lancet. 2004;364:137-138.

APR 2018

Antiretroviral Pregnancy Registry. Interim Report Jan 31, 2018. Available at: http://www.apregistry.com/Default.aspx. Accessed July 20, 2018.

Aras 2012

Aras S, Varli M, Uzun B, Atli T, Keven K, Turgay M. Comparison of different glomerular filtration methods in the elderly: which formula provides better estimates? Ren Fail 2012; 34(4):435-441. doi: 410.3109/0886022X.0882011.0654168. Epub 0882012 Jan 0886024.

Armah 2012

Armah KA, McGinnis K, Baker J, Gibert C, Butt AA, Bryant KJ, et al. HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation. Clin Infect Dis 2012; 55(1):126-136.

Armstrong 2017

Armstrong, N.M. et al., (2018) Optimal metrics for identifying long term patterns of depression in older HIV-infected and HIV-uninfected men who have sex with men. Aging Ment Health: Feb 9:1-8 doi:10.1080/13607863.2017.1423037

Arnett 2019

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., . . . Ziaeian, B. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e563-e595. doi:10.1161/CIR.0000000000000677

Arnsten 2007

Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007,21:617-623.

Arribas 2014

Arribas JR, Pialoux G, Gathe J, et al. Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase IIIb, non-inferiority trial. Lancet Infect Dis. 2014;14:581-589.

Arribas 2017

Arribas JR, Thompson M, Sax PE, et al. Significant efficacy and long-term safety difference with TAF-based STR in naïve adults. Program and abstracts of the 2017 Conference on Retroviruses and Opportunistic Infections; February 13-16, 2017; Seattle, Washington. Abstract 453.

Arthos 2008

Arthos J, Cicala C, Martinelli E, et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat Immunol. 2008;9:301-309.

ASHSP 2016

American Society of Health Systems Pharmacists. (2015). ASHP Guidelines on Pharmacist Involvement in HIV Care. In: ASHP best practices. Position & Guidance Documents of ASHP 2015-2016 edition. Bethesda: American Society of Health Systems Pharmacists.

ATCC 2010

Antiretroviral Therapy Cohort C. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50(10):1387-1396.

Atkinson 2009

Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. AIDS Patient Care STDS 11 (2009):903–14.

Atta 2006

Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 10 (2006):2809.

Pages

Connect

Phone: 202-659-0699
Fax: 202-659-0976

Contact

AAHIVM National Office
1627 Eye St NW Suite 835
Washington, D.C. 20006

About

The American Academy of HIV Medicine is a professional organization that supports the HIV practitioner and promotes accessible, quality care for all Americans living with HIV disease. Our membership of HIV practitioners and credentialed HIV Specialists™, HIV Experts™, and HIV Pharmacists™ provide direct care to the majority of HIV patients in the US.